Diagnostic potential of automated subcortical volume segmentation in atypical parkinsonism

Neurology

Volumn 86, Issue 13, 2016, Pages 1242-1249

  Scherfler, Christoph ^a   Göbel, Georg ^b   Müller, Christoph ^a   Nocker, Michael ^a   Wenning, Gregor K ^a   Schocke, Michael ^c   Poewe, Werner ^a   Seppi, Klaus ^a  

^a Departments of Neurology   (Austria)

^b Informatics and Health Economics   (Austria)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN SIZE; DIAGNOSTIC ACCURACY; DISEASE DURATION; FEMALE; FOLLOW UP; GRAY MATTER; HUMAN; MAJOR CLINICAL STUDY; MALE; MESENCEPHALON; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PUTAMEN; SHY DRAGER SYNDROME; UNIFIED PARKINSON DISEASE RATING SCALE; CEREBELLUM; MIDDLE AGED; ORGAN SIZE; PARKINSONIAN DISORDERS; PATHOLOGY; PROCEDURES; SUPRANUCLEAR PALSY, PROGRESSIVE;

AGED; CEREBELLUM; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MESENCEPHALON; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; ORGAN SIZE; PARKINSONIAN DISORDERS; PUTAMEN; SUPRANUCLEAR PALSY, PROGRESSIVE;

EID: 84962890414     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000002518     Document Type: Article

References (32)

1. Hughes AJ, Daniel SE, Ben-Shlomo Y, Lees AJ. The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain 2002;125: 861-870
2. Litvan I, Agid Y, Calne D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele- Richardson-Olszewski syndrome): report of the NINDSSPSP international workshop. Neurology 1996;47:1-9
3. Litvan I, Goetz CG, Jankovic J, et al. What is the accuracy of the clinical diagnosis of multiple system atrophy? A clinicopathologic study. Arch Neurol 1997;54:937-944
4. Mahlknecht P, Hotter A, Hussl A, Esterhammer R, Schocke M, Seppi K. Significance of MRI in diagnosis and differential diagnosis of Parkinsons disease. Neurodegener Dis 2010;7:300-318
5. Messina D, Cerasa A, Condino F, et al. Patterns of brain atrophy in Parkinsons disease, progressive supranuclear palsy and multiple system atrophy. Parkinsonism Relat Disord 2011;17:172-176
6. Fischl B, Dale AM. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci USA 2000;97:11050-11055
7. Verma R, Zacharaki EI, Ou Y, et al. Multi-parametric tissue characterization of brain neoplasms and their recurrence using pattern classification of MR images. Acad Radiol 2008;15:966-977
8. Zacharaki EI, Wang S, Chawla S, et al. Classification of brain tumor type and grade using MRI texture and shape in a machine learning scheme. Magn Reson Med 2009;62: 1609-1618
9. Kuhn M, Johnson K. Applied Predictive Modelling. New York: Springer; 2013
10. Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinsons disease. J Neurol Neurosurg Psychiatry 1988;51:745-752
11. Gilman S, Wenning GK, Low PA, et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology 2008;71:670-676
12. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967;17:427-442
13. Fahn S, Elton RL. Members of the Unified Parkinsons Disease Rating Scale Development Committee: Unified Parkinsons Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M, eds. Recent Developments in Parkinsons Disease, vol 2 Florham Park, NJ: Macmillan Healthcare Information; 1987:153-164
14. Schmidt R, Enzinger C, Ropele S, Schmidt H, Fazekas F; Austrian Stroke Prevention study. Progression of cerebral white matter lesions: 6-year results of the Austrian Stroke Prevention study. Lancet 2003;14:2046-2048
15. Quinlan JR. C4.5: Programs for Machine Learning. San Mateo, CA: Morgan Kaufmann, Publishers; 1993
16. Hall M, Frank E, Holmes G, Pfahringer B, Reutermann P, Witten ICH. The WEKA data mining software: an update. ACM SIGKDD Explorations Newsletter 2009; 11:10-18
17. Catafau AM, Tolosa E; DaTSCAN Clinically Uncertain Parkinsonian Syndromes Study Group. Impact of dopamine transporter SPECT using 123I-Ioflupane on diagnosis and management of patients with clinically uncertain Parkinsonian syndromes. Mov Disord 2004;19:1175-1182
18. Williams DR, de Silva R, Paviour DC, et al. Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardsons syndrome and PSP-parkinsonism. Brain 2005;128: 1247-1258
19. Osaki Y, Ben-Shlomo Y, Lees AJ, et al. Accuracy of clinical diagnosis of progressive supranuclear palsy. Mov Disord 2004;19:181-189
20. Osaki Y, Ben-Shlomo Y, Lees AJ, Wenning GK, Quinn NP. A validation exercise on the new consensus criteria for multiple system atrophy. Mov Disord 2009;24: 2272-2276
21. Steele JC, Richardson JC, Olszewski J. Progressive supranuclear palsy: a heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol 1964;10:333-359
22. Morris HR, Gibb G, Katzenschlager R, Wood NW, Hanger DP, Strand C. Pathological, clinical and genetic heterogeneity in progressive supranuclear palsy. Brain 2002;125:969-975
23. Liscic RM, Srulijes K, Groger A, Maetzler W, Berg D. Differentiation of progressive supranuclear palsy: clinical, imaging and laboratory tools. Acta Neurol Scand 2013; 127:362-370
24. Paviour DC, Price SL, Jahanshahi M, Lees AJ, Fox NC. Regional brain volumes distinguish PSP, MSA-P, and PD: MRI-based clinico-radiological correlations. Mov Disord 2006;21:989-996
25. Longoni G, Agosta F, Kostic VS, et al. MRI measurements of brainstem structures in patients with Richardsons syndrome, progressive supranuclear palsy-parkinsonism, and Parkinsons disease. Mov Disord 2011;26:247-255
26. Dickson DW, Ahmed Z, Algom AA, Tsuboi Y, Josephs KA. Neuropathology of variants of progressive supranuclear palsy. Curr Opin Neurol 2010;23:394-400
27. Fanciulli A, Wenning GW. Multiple-system atrophy. N Engl J Med 2015;372:249-263
28. Schulz JB, Skalej M, Wedekind D, et al. Magnetic resonance imaging-based volumetry differentiates idiopathic Parkinsons syndrome from multiple system atrophy and progressive supranuclear palsy. Ann Neurol 1999;45:65-74
29. Ghaemi M, Hilker R, Rudolf J, Sobesky J, Heiss WD. Differentiating multiple system atrophy from Parkinsons disease: contribution of striatal and midbrain MRI volumetry and multi-tracer PET imaging. J Neurol Neurosurg Psychiatry 2002;73:517-523
30. Shigemoto Y, Matsuda H, Kamiya K, et al. In vivo evaluation of gray and white matter volume loss in the parkinsonian variant of multiple system atrophy using SPM8 plus DARTEL for VBM. Neuroimage Clin 2013;2:491-496
31. Appelman AP, Vincken KL, van der Graaf Y, et al; SMART Study Group. White matter lesions and lacunar infarcts are independently and differently associated with brain atrophy: the SMART-MR study. Cerebrovasc Dis 2010;29:28-35
32. Massey LA, Jger HR, Paviour DC, et al. The midbrain to pons ratio: a simple and specific MRI sign of progressive supranuclear palsy. Neurology 2013;80:1856-1861